www.fdanews.com/articles/178639-janssen-gains-fda-approval-for-type-2-diabetes-combo-drug-invokamet
Janssen Gains FDA Approval for Type 2 Diabetes Combo Drug Invokamet XR
September 29, 2016
The FDA approved Janssen’s Invokamet XR, a once-daily combination of canagliflozin and metformin hydrochloride, for use with diet and exercise to improve blood glucose control in adults with type 2 diabetes.
Invokamet XR combines Invokana (canagliflozin) and an extended release formulation of metformin.